| 陆海波,鲁传华.高尿酸血症治疗药物黄嘌呤氧化酶抑制剂的研究进展[J].安徽医药,2016,20(4):626-630. |
| 高尿酸血症治疗药物黄嘌呤氧化酶抑制剂的研究进展 |
| Research process of xanthine oxidase inhibitors as hyperuricemia drugLU Hai-bo,LU Chuan-hua (School of Pharmacy,Anhui University of Chinese Medicine,Hefei, Anhui 230012,China)Abstract: |
| 投稿时间：2015-11-19 |
| DOI： |
| 中文关键词: 高尿酸血症 痛风 尿酸 黄嘌呤氧化酶 |
| 英文关键词: hyperuricemia gout uric acid xanthine oxidase 考文献: |
| 基金项目: |
|
| 摘要点击次数: 3825 |
| 全文下载次数: 336 |
| 中文摘要: |
| 高尿酸血症是由多种原因引起的代谢性疾病,黄嘌呤氧化酶(XO)是药物治疗高尿酸血症的重要靶点。随着黄嘌呤氧化酶晶体结构的解析、计算机辅助药物设计和高通量筛选等技术的运用,近年涌现了许多具有良好的XO抑制活性的化合物。中药也是我国治疗高尿酸血症的一种主要方式,对天然化合物进行结构修饰也是寻找新化合物的重要方法。该文基于高尿酸血症的产生机制,对具有良好XO抑制活性化合物进行综述。 |
| 英文摘要: |
| Hyperuricemia is a metabolic disease resulting from multiple factors,and xanthine oxidase (XO) is an important target for hyperuricemia therapy.Due to the determination of crystal structure of the enzyme and application of CADD and HTS,there emerge a large number of xanthine oxidase inhibitors which have good activity for lowering uric acid in recent years.Using traditional Chinese medicine to treat hyperuricemia is prevalent in China. It is an important method to modificate natural product to find new compounds.In this article,we review the compounds which have excellent inhibitory activity of xanthine oxidase based on the pathological mechanism. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
